| The X-ray crystal structure of full-length human plasminogen RHP Law, T Caradoc-Davies, N Cowieson, AJ Horvath, AJ Quek, ... Cell reports 1 (3), 185-190, 2012 | 253 | 2012 |
| Tranexamic acid is an active site inhibitor of urokinase plasminogen activator G Wu, BA Mazzitelli, AJ Quek, MJ Veldman, PJ Conroy, ... Blood advances 3 (5), 729-733, 2019 | 41 | 2019 |
| X-ray crystal structure of plasmin with tranexamic acid–derived active site inhibitors RHP Law, G Wu, EWW Leung, K Hidaka, AJ Quek, TT Caradoc-Davies, ... Blood advances 1 (12), 766-771, 2017 | 38 | 2017 |
| Structural studies of plasmin inhibition G Wu, AJ Quek, TT Caradoc-Davies, SM Ekkel, B Mazzitelli, JC Whisstock, ... Biochemical Society Transactions 47 (2), 541-557, 2019 | 33 | 2019 |
| Gas‐generating, pH‐responsive calcium carbonate hybrid particles with biomimetic coating for contrast‐enhanced ultrasound imaging MLP Vidallon, AM Douek, A Quek, H McLiesh, J Kaslin, RF Tabor, ... Particle & Particle Systems Characterization 37 (2), 1900471, 2020 | 31 | 2020 |
| Dimerization is not a determining factor for functional high affinity human plasminogen binding by the group A streptococcal virulence factor PAM and is mediated by specific … S Bhattacharya, Z Liang, AJ Quek, VA Ploplis, R Law, FJ Castellino Journal of Biological Chemistry 289 (31), 21684-21693, 2014 | 25 | 2014 |
| A mechanism for hereditary angioedema caused by a lysine 311–to–glutamic acid substitution in plasminogen SK Dickeson, S Kumar, MF Sun, BM Mohammed, DR Phillips, ... Blood, The Journal of the American Society of Hematology 139 (18), 2816-2829, 2022 | 22 | 2022 |
| Polynorepinephrine as an efficient antifouling-coating material and its application as a bacterial killing photothermal agent Z Lu, AJ Quek, SP Meaney, RF Tabor, B Follink, BM Teo ACS Applied Bio Materials 3 (9), 5880-5886, 2020 | 13 | 2020 |
| Structure and function characterization of the a1a2 motifs of Streptococcus pyogenes M protein in human plasminogen binding AJH Quek, BA Mazzitelli, G Wu, EWW Leung, TT Caradoc-Davies, ... Journal of molecular biology 431 (19), 3804-3813, 2019 | 12 | 2019 |
| Human plasminogen exacerbates Clostridioides difficile enteric disease and alters the spore surface MM Awad, ML Hutton, AJ Quek, WP Klare, SJ Mileto, K Mackin, D Ly, ... Gastroenterology 159 (4), 1431-1443. e6, 2020 | 10 | 2020 |
| Solution structural model of the complex of the binding regions of human plasminogen with its M-protein receptor from Streptococcus pyogenes Y Yuan, YA Ayinuola, D Singh, O Ayinuola, JA Mayfield, A Quek, ... Journal of structural biology 208 (1), 18-29, 2019 | 9 | 2019 |
| Preferential acquisition and activation of plasminogen glycoform II by PAM positive group A streptococcal isolates DMP De Oliveira, RHP Law, D Ly, SM Cook, AJ Quek, JD McArthur, ... Biochemistry 54 (25), 3960-3968, 2015 | 8 | 2015 |
| Impact of Plasminogen on Clostridioides difficile Colitis RHP Law, GJ Lloyd, AJ Quek, JC Whisstock IntechOpen, 2024 | | 2024 |
| Fusion proteins JC Whisstock, RHP Law, AJ Quek, C Hagemeyer, M Martino, G Wu, YZ Lu US Patent App. 18/273,156, 2024 | | 2024 |
| A High-Throughput Small-Angle X-ray Scattering Assay to Determine the Conformational Change of Plasminogen AJ Quek, NP Cowieson, TT Caradoc-Davies, PJ Conroy, JC Whisstock, ... International Journal of Molecular Sciences 24 (18), 14258, 2023 | | 2023 |
| Antibodies for binding plasmin J Whisstock, R Law, A Quek, P Conroy, G Wu US Patent App. 17/772,090, 2023 | | 2023 |
| Antibodies for binding plasminogen J Whisstock, R Law, A Quek, P Conroy, D Lyras, G Wu US Patent App. 17/771,982, 2022 | | 2022 |
| Methods for making recombinant protein J Whisstock, R Law, A Quek, P Conroy US Patent App. 17/626,168, 2022 | | 2022 |
| Toward Better Understanding on How Group A Streptococcus Manipulates Human Fibrinolytic System AJH Quek, JC Whisstock, RHP Law Staphylococcus and Streptococcus, 2019 | | 2019 |
| Structure and Function Characterization of AJH Quek, BA Mazzitelli, G Wu, EWW Leung, TT Caradoc-Davies, ... | | |
